Abstract
This chapter addresses risks and radiation protection aspects in medical exposures when embryo/foetus or infants are involved, following exposures of pregnant women or breastfeeding women, including patients or workers.
The effects of radiation in prenatal exposures in the different periods of pregnancy from preimplantation to embryonic and foetal periods, taking into consideration, among others, the effects on mental development and the carcinogenic risks, are presented.
Diagnostic and therapeutic nuclear medicine procedures in relation to pregnancy are considered.
Patients administered with radiopharmaceuticals normally have family members at home, other persons taking care or giving comfort to the patient and close friends; thus, radiation protection takes into account also the protection of these individuals and in particular of children and pregnant females among them.
In nuclear medicine, the staff members should pay attention in handling radiopharmaceuticals in relation to external and internal exposures, in particular for 131I therapeutic doses. A pregnant or breastfeeding female worker should not work in areas of significant contamination risk.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ICRP (2000) Pregnancy and medical radiation, ICRP Publication 84. Ann ICRP 30(1)
ICRP (2001) Doses to the embryo and fetus from intakes of radionuclides by the mother, ICRP Publication 88. Ann ICRP 31(1–3)
ICRP (2003) Biological effects after prenatal irradiation (embryo and fetus), ICRP Publication 90. Ann ICRP 33(1–2)
ICRP (2007) Radiological protection, ICRP Publication 105. Ann ICRP 37(6)
ICRP (2008) Radiation dose to patients from radiopharmaceuticals – addendum 3 to publication 53, ICRP Publication 106. Ann ICRP 38(1–2)
Council of the European Union (1997) Council Directive 97/43 Euratom of 30 June 1997 on health protection of individuals against the dangers of ionising radiation in relation to medical exposures. Off J Eur Commun L-180, 22–27. Luxembourg: Office for the Official Publications of the European Communities
Commission E (1998) Guidance for protection of unborn children and infants irradiated due to parental medical exposures. Radiation protection 100. Office for the Official Publications of the European Communities, Luxembourg
Guidance on the application of dose coefficients for the embryo, fetus and breastfed infants in dose assessments for members of the public. Advice from the Health Protection Agency. Documents of the HPA-Radiation, Chemical and Environmental Hazards. RCE-58, March 2000. ISBN 978-0-85951-614-3
Protection of pregnant patients during diagnostic medical exposures to ionising radiation. Advice from the Health Protection Agency, the Royal College of Radiologists and the College of Radiographers. Documents of the HPA-Radiation, Chemical and Environmental Hazards. RCE-9, March 2009. ISBN 978-0-85951-635-8
Hall EJ (1994) Radiobiology for the radiologist, 4th edn. J.B. Lippincott Co., Philadelphia, PA, USA
Gu Y, Kai M, Kusama T (1997) The embryonic and fetal effects in ICR mice irradiated in the various stages of the preimplantation period. Radiat Res 147:735–740
Streffer C, Müller W-U (1996) Malformations after radiation exposure of preimplantation stages. Int J Dev Biol 40:355–360
OECD (1988) The biological basis for the control of prenatal irradiation. Report by a Group of Consultants, Paris, France
Konermann G (1982) Consequences of prenatal radiation exposure for perinatal and postnatal development: morphological, biochemical and histochemical aspects. In: Kriegel H, Schmahl W, Kistner G, et al (eds) Developmental effects of prenatal irradiation. Gustav Fischer Verlag, Stuttgart, Germany, pp 237–250
Otake M, Schull WJ (1984) In utero exposure to A-bomb radiation and mental retardation. A reassessment. Br J Radiol 57:409–414
Gilman E, Kneale G, Knox E et al (1988) Pregnancy x-rays and childhood cancers: effects of exposure age and radiation dose. J Radiat Protect 8:3–8
Monson RR, McMahon B (1984) Prenatal x-ray exposure and cancer in children. In: Boice J, Fraumeni J (eds) Radiation carcinogenesis: epidemiology and biological significance. Raven, New York, USA, pp 97–105
ICRP (2007) Recommendations of the International Commission on Radiological Protection, ICRP Publication 103. Ann ICRP 37(2–4)
Russell JR, Stabin MG, Sparks RB, Watson EE (1997) Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. J Nucl Med 73:756–769
Loevinger R, Budinger TF, Watson EE (1991) MIRD primer for absorbed dose calculations. Society of Nuclear Medicine, New York, NY
Cristy M, Eckerman K (1987) Specific absorbed fractions of energy at various ages from internal photon sources. ORNL/TM-8381 V1–V7. Oak Ridge National Laboratory, Oak Ridge, TN
Stabin MG, Watson EE, Cristy M et al (1995) Mathematical models and specific absorbed fractions of photon energy in the nonpregnant adult female and at the end of each trimester of pregnancy. ORNL/TM-12907. Oak Ridge National Laboratory, Oak Ridge, TN
Zankl M, Petoussi-Henss N, Fill U, Regulla D (2003) The application of voxel phantoms to the internal dosimetry of radionuclides. Radiat Prot Dosim 105:539–548
Kramer R, Khoury HJ, Vieira JW, Loureiro ECM, Lima VJM, Lima FRA, Hoff G (2004) All about FAX: a female adult voxel phantom for Monte Carlo calculations in radiation protection dosimetry. Phys Med Biol 49:5203–5216
Petoussi-Henss N, Bolch WE, Zankl M, Sgouros G, Wessels B (2007) Patient-specific scaling of reference S-values for cross-organ radionuclides S-values: what is appropriate? Radiat Prot Dosim 127:192–196
Shi CY, Xu XG, Stabin MG (2008) SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys 35:3215–3224
Goo BQ, Xu XG, Shi C (2010) Specific absorbed fractions for internal electron emitters derived for a set of anatomically realistic reference pregnant female models. Radiat Prot Dosim 138(1):20–28
Xu XG (Rensselaer Polytechnic Institute, USA – the consortium of computational human phantoms (CCHP). http://www.virtualphantoms.org/index.html)
Watson EE (1992) Radiation absorbed dose to the human foetal thyroid. In: S-Stelson A, Watson EE (eds) 5th international radiopharmaceutical dosimetry symposium, CONF-910529, Oak Ridge Associated Universities, Oak Ridge, TN, USA, p 179–187
National Council on Radiation Protection and Measurements NCRP (1998) Radionuclide exposure of the embryo/fetus. Report 128. NCRP, Bethesda. http://www.ncrppublications.org/Reports/128
Berkovski V (1999) Radioiodine biokinetics in the mother and fetus. Part 1. Pregnant woman. In: Radiation and Thyroid Cancer. World Scientific Publishing. Publication No. EUR 18552 EN of the European Commission, pp 319–325
Berkovski V (1999b) Radioiodine biokinetics in the mother and fetus. Part 2. Fetus. In: Radiation and Thyroid Cancer. World Scientific Publishing. Publication No. EUR 18552 EN of the European Commission, pp 327–332
Anspaugh LR, Napier BA (2009) Minor parameters need for individual dose calculations, PNNL-18917. Pacific Northwest National Laboratory, Richland, WA
Berg GEB, Nyström EH, Jacobsson L, Lindberg S, Lindstedt RG, Mattsson S, Niklasson CA, Norén AH, Westphal OGA (1998) Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 39(2):357–361
ICRP (1992) Radiological protection in biomedical research ICRP Publication 62. Ann ICRP 22(3)
Ahlgren L, Ivarsson S, Johansson L, Mattsson S, Nosslin B (1985) Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J Nucl Med 26:1085–1090
Mountford PJ, Coakle AJ (1989) A review of the secretion of radioactivity in human breast milk: data, quantitative analysis and recommendations. Nucl Med Commun 10(1):15–27
Stabin MG, Breitz HB (2000) Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry. J Nucl Med 41:863–873
Safety guide for radiation protection in nuclear medicine. Australian Radiation Protection and Nuclear Safety Agency, Radiation Protection Series Publication No. 14.2, 2008. ISBN 978-0-9805638-0-1, ISSN 1445-9760
Treves ST (ed) (2007) Pediatric nuclear medicine/PET, 3rd edn. Heidelberg, Springer. ISBN 038732321X
Gray L, Torreggiani W, O’Reilly G (2008) Paediatric diagnostic reference levels in nuclear medicine imaging in Ireland. Brit J Radiol 81:918–919
Ted Treves S, Davis RT, Fahey FH (2008) Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med 49:1024–1027
Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, Dosimetry EANM, Committees P (2007) The new EANM paediatric dosage card. Eur J Nucl Med Mol Imag 34(5):796–798
Lassmann M, Biassoni L, Monsieurs M, Franzius C (2008) EANM dosimetry and paediatrics committees. The New EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imag 35(9):1666–1668
Gelfand MJ, Prisi MT, Ted Treves S (2011) Pediatric radiopharmaceutical administered doses: 2010 North America consensus guidelines. J Nucl Med 52(2):318–322
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cantone, M.C. (2013). Radiation Exposure of the Embryo/Foetus and the Newborn Child. In: Mattsson, S., Hoeschen, C. (eds) Radiation Protection in Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31167-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-31167-3_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31166-6
Online ISBN: 978-3-642-31167-3
eBook Packages: MedicineMedicine (R0)